Search results
DOJ Proposes to Reschedule Marijuana (Cannabis) To Schedule III
The National Law Review· 5 days agoFollowing a comprehensive review by the US Department of Health and Humans Services (HHS) on cannabis’s safety and subsequent recommendation to the < ...
JD Supra: FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests
JD Supra· 4 days agoYesterday, the Food & Drug Administration (“FDA” or “the Agency”) issued a highly anticipated – and highly controversial ...
Anti-Obesity Medications: Noteworthy Developments as Policymakers Weigh Coverage Considerations | JD...
JD Supra· 7 days agoGLP-1 agonists have ushered in a new era in anti-obesity medication policy considerations against the backdrop of a continued focus by policymakers on both drug access < ...
Louisiana Becomes First State to Classify Mifepristone and Misoprostol as Controlled Substances
The National Law Review· 5 days agoOn May 25, 2024, Louisiana Governor Jeff Landry signed a bill, SB 276, into law that will classify medications commonly used in pregnancy and to treat stomach ulcers (mifepristone ...
‘DEVASTATED’: Documentary presents personal tragedies, the fight against Colorado’s fentanyl crisis
Greeley Tribune· 5 days agoSteffan Tubbs was hosting his self-titled show on a 5,000-watt AM radio station in Denver when he...
Considering clinically relevant herb-drug interactions 30 years on
Nutraingredients.com· 5 days agoDuring this period, one of the fastest-growing segments has been products formulated with...
Analysis | Patients of color struggle to get attention for long covid
Washington Post· 7 days agoToday’s edition: Harm-reduction groups are facing pushback from critics of “safe smoking” supplies....
JD Supra: OHRP FY 25 Budget Request Lacks Prior Plea For Funding, Staff Increases; Plans Are Modest
JD Supra· 3 days agoThus, the situation for this critical oversight agency will not improve anytime soon, and it is likely to continue operating with at least seven fewer staff members than OHRP ...
2023 Highlights in Canadian Life Sciences IP and Regulatory Law | JD Supra
JD Supra· 5 days agoFollowing a summary trial, Lilly’s infringement actions were dismissed: composition claims directed to “a physiologically acceptable salt” of tadalafil were found invalid for overbreadth (broader ...
Mandatory Cybersecurity Incident Reporting: The Dawn of a New Era for Businesses
The National Law Review· 2 days agoA significant shift in cybersecurity compliance is on the horizon, and businesses need to prepare....